Literature DB >> 28134026

Burden of illness of people with persistent symptoms of schizophrenia: A multinational cross-sectional study.

Anna-Lena Nordstroem1, Darren Talbot1, Corrado Bernasconi1, Carmen Galani Berardo2, Justine Lalonde1.   

Abstract

BACKGROUND: Few studies have examined the impact of persistent symptoms of schizophrenia, especially with respect to patient-reported outcomes (PROs), carer burden and health economic impact. AIMS: Analyse data relating to burden and severity of illness, functional impairment and quality of life for patients with persistent symptoms of schizophrenia.
METHODS: A cohort of stable outpatients with persistent symptoms of schizophrenia across seven countries were assessed in a multicentre, non-interventional, cross-sectional survey and retrospective medical record review using PRO questionnaires, clinical rating scales and carer questionnaires.
RESULTS: Overall, 1,421 patients and 687 carers were enrolled. Approximately two-thirds of patients had moderate/mild schizophrenia with more severe negative symptoms predominating. Patients showed impaired personal/social functioning and unsuitability for work correlated with various patient factors, most notably symptom-related assessments. Quality-of-life assessments showed 25% to ⩾30% of patients had problems with mobility, washing or dressing. Carer burden was also considerable, with carers having to devote an average of 20.5 hours per week and notable negative impact on quality-of-life measures. Healthcare resource utilisation for in-hospital, outpatient and other care provider visits was significant.
CONCLUSION: These results demonstrate the significant burden of schizophrenia for patients, carers and society and highlight the need for improved treatment approaches.

Entities:  

Keywords:  Schizophrenia; burden of illness; functional impairment; persistent symptoms; quality of life

Mesh:

Year:  2017        PMID: 28134026     DOI: 10.1177/0020764016688040

Source DB:  PubMed          Journal:  Int J Soc Psychiatry        ISSN: 0020-7640


  8 in total

1.  Using World Health Organization Disability Assessment Schedule 2.0 in people with schizophrenia: a 4-year follow-up.

Authors:  Ruey Chen; Tsan-Hon Liou; Nae-Fang Miao; Kwang-Hwa Chang; Chia-Feng Yen; Hua-Fang Liao; Wen-Chou Chi; Kuei-Ru Chou
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-04-22       Impact factor: 5.270

2.  Treatment outcomes in schizophrenia: qualitative study of the views of family carers.

Authors:  Joanne Lloyd; Helen Lloyd; Ray Fitzpatrick; Michele Peters
Journal:  BMC Psychiatry       Date:  2017-07-21       Impact factor: 3.630

3.  Measuring the Burden of Schizophrenia Using Clinician and Patient-Reported Measures: An Exploratory Analysis of Construct Validity.

Authors:  Matthew Franklin; Clara Mukuria; Brendan Mulhern; Irwin Tran; John Brazier; Stuart Watson
Journal:  Patient       Date:  2019-08       Impact factor: 3.883

4.  Effect of Paliperidone Palmitate 3-Month Formulation on Goal Attainment and Disability After 52 Weeks' Treatment in Patients with Clinically Stable Schizophrenia.

Authors:  Martin Lambert; Pedro Sanchez; Paul Bergmans; Srihari Gopal; Maju Mathews; Annette Wooller; Katalin Pungor
Journal:  Neuropsychiatr Dis Treat       Date:  2020-12-23       Impact factor: 2.570

5.  EPA guidance on assessment of negative symptoms in schizophrenia.

Authors:  S Galderisi; A Mucci; S Dollfus; M Nordentoft; P Falkai; S Kaiser; G M Giordano; A Vandevelde; M Ø Nielsen; L B Glenthøj; M Sabé; P Pezzella; I Bitter; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-02-18       Impact factor: 5.361

6.  Clinical Predictors of Duration of Untreated Psychosis: Exploring Psychosocial and Clinical Predictors of Duration of Untreated Psychosis in First-Episode Psychotic Patients in Mzuzu, Malawi.

Authors:  Japhet Myaba; Charles M Mwale; Vincent C Jumbe
Journal:  Malawi Med J       Date:  2021-04       Impact factor: 1.413

7.  Peripheral Biomarkers for First-Episode Psychosis-Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia.

Authors:  Nuno Trovão; Joana Prata; Orlando VonDoellinger; Susana Santos; Mário Barbosa; Rui Coelho
Journal:  Psychiatry Investig       Date:  2019-03-07       Impact factor: 2.505

8.  Understanding the Economic Value and Impacts on Informal Carers of People Living with Mental Health Conditions.

Authors:  David McDaid; A-La Park
Journal:  Int J Environ Res Public Health       Date:  2022-03-01       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.